Seen & Heard

Glaucoma Today

Innovations in Glaucoma: The FYSX OPAP Device John P. Berdahl, MD, inventor of the FYSX Ocular Pressure Adjusting Pump (Balance Ophthalmics), joins the set of Innovation Journal Club to share insights into the device, pearls for patient selection, and tips for using it in practice. Dr. Berdahl also discusses data from the pivotal trial of the FYSX device, which showed IOP lowering in 100% of eyes with normal-tension glaucoma. Customizing Care and Minimizing Risk With MIGS On GT: The Podcast, Reay H. Brown, MD, and Shibandri Das, MD, each present a scenario that highlights how minimally invasive procedures can be used to address specific obstacles in glaucoma management. The two patient cases were featured in their article, “Customizing Care and Minimizing Risk With MIGS,” which was written with Shivani Kamat, MD, and featured in the May/June 2026 issue of Glaucoma Today. When a Minimally Invasive Procedure Fails On MIGS Unplugged, hosts Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, sit down with Rachel G. Simpson, MD, to reflect on the role of trabeculectomy in today’s glaucoma treatment landscape.

Educating Patients on Presbyopia Treatments

Getting patient buy-in and satisfaction is contingent on managing their expectations.

Ethin Kiekhafer, OD, FAAO, Jacob Lang, OD, FAAO

Modern Optometry

A Potential Digital Co-Pilot in the Retina OR

AI systems may one day augment traditional surgical workflows to improve efficiency and patient outcomes.

Stanley Poh, MBBS, MMed (Ophth), FRCOphth, FAMS, and Daniel Ting, MD, PhD

Retina Today

KEY TAKEAWAYS By analyzing large volumes of data, AI could generate clinically meaningful insights to enable more informed decision making in the OR. AI could identify high-risk cases and flag factors such as suboptimal glycemic control, anticoagulant use, medical comorbidities, drug allergies, and mobility limitations. Agentic AI can act as a digital co-pilot by integrating preoperative, intraoperative, and postoperative capabilities. Vitreoretinal surgery is a complex discipline involving intricate and highly variable pathology. Many decisions depend on dynamic changes in anatomy and tissue behavior, surgical visualization, and potential complications. As such, vitreoretinal fellows face a steep learning curve. Years of training through residency, fellowship, and independent surgical practice are required to develop the judgement needed to determine whether surgery is warranted, which intervention is most appropriate, and how urgently it should be performed. As AI tools proliferate and improve, they could advance the evolution of the retina OR. By analyzing large volumes of clinical, imaging, and procedural data, AI could generate timely, clinically meaningful insights to enable more informed decision making across preoperative, intraoperative, and postoperative phases of care (Figure). In many ORs, digital visualization systems and intraoperative OCT have already broadened what surgeons can see and have influenced surgical decision making.